Endocrine Disruptor Screening Program; Workshop to Discuss Draft Policies and Procedures, 65732-65733 [E7-22895]
Download as PDF
65732
Federal Register / Vol. 72, No. 225 / Friday, November 23, 2007 / Notices
Rating EC2.
EIS No. 20070445, ERP No. D–USN–
E11063–00, Shock Trail of the MESA
VERDE (LPD 19), San Antonio (LPD 17)
Class Ship designated as the Shock Ship
for Proposed Shock Trail, Possible
Offshore Locations are Naval Station
Norfolk, VA; Naval Station Mayport, FL;
and Naval Air Station Pensacola, FL.
Summary: EPA expressed
environmental concerns about impacts
to avian and marine species.
Rating EC1.
EIS No. 20070364, ERP No. DS–COE–
E01013–FL, Rock Mining in the Lake
Belt Region Plan, Continuance of
Limestone Mining Construction, section
404 Permit, Miami-Dade County, FL.
Summary: EPA expressed
environmental concerns about water
quality, wetland and mining-related
seepage impacts, and requested
additional mitigation and monitoring
measures.
Rating EC2.
Dated: November 19, 2007.
Robert W. Hargrove,
Director, NEPA Compliance Division, Office
of Federal Activities.
[FR Doc. E7–22851 Filed 11–21–07; 8:45 am]
BILLING CODE 6560–50–P
ENVIRONMENTAL PROTECTION
AGENCY
[ER–FRL–6693–2]
mstockstill on PROD1PC66 with NOTICES
Environmental Impact Statements;
Notice of Availability
Responsible Agency: Office of Federal
Activities, General Information, (202)
564–7167 or https://www.epa.gov/
compliance/nepa/
Weekly receipt of Environmental Impact
Statements
Filed 11/12/2007 through 11/16/2007
Pursuant to 40 CFR 1506.9.
EIS No. 20070495, Final Supplement,
APH, 00, Importation of Solid Wood
Packing Material, To Reevaluate and
Refine Estimates of Methyl Bromide
Usage in the Treatment,
Implementation, United States. Wait
Period Ends: 12/24/2007. Contact:
David A. Bergston, 301–734–6103.
EIS No. 20070496, Draft EIS, FRC, 00,
Fayetteville/Greenville Expansion
Project, Construction and Operation
of the Natural Gas Pipeline Facilities
in Arkansas and Mississippi.
Comment Period Ends: 01/07/2008.
Contact: Andy Black, 1–866–208–
3372.
EIS No. 20070497, Draft EIS, FAA, CA,
Horizon Air Service to Mammoth
Yosemite Airport Project, Proposed
Operations Specifications
VerDate Aug<31>2005
16:16 Nov 21, 2007
Jkt 214001
Amendment to Provide Scheduled Air
Service, Town of Mammoth Lakes,
Mono County, CA. Comment Period
Ends: 01/11/2008. Contact: Chuck
Cox, 425–227–2243.
EIS No. 20070498, Draft EIS, FHW, UT,
I–15 Corridor Project, Transportation
Improvement from Utah County to
Salt Lake County, UT. Comment
Period Ends: 01/11/2008. Contact:
Carlos Machado, 801–963–0182.
EIS No. 20070499, Final EIS, FRC, 00,
Klamath Hydroelectric Project,
Continued Operation for Hydropower
License FERC No. 2082–27, Klamath
River, Klamath County, OR and
Siskiyou County, CA. Wait Period
Ends: 12/24/2007. Contact: John
Mudre, 202–502–8902.
Amended Notices
EIS No. 20070409, Draft EIS, AFS, MT,
Beartooth Ranger District Travel
Management Planning, Proposing to
Designate Routes for Public Motorized
Use, and Change Management of Pack
and Saddle Stock on Certain Trail,
Beartooth Ranger District, Custer
National Forest, Carbon, Stillwater,
Sweet Grass, and Park Counties, MT.
Comment Period Ends: 12/19/2007.
Contact: Doug Epperly, 406–657–6205
Ext 225. Revision for FR Notice
Published 10/05/2007: Extending
Comment Period from 11/19/2007 to
12/19/2007.
EIS No. 20070478, Final EIS, AFS, AK,
Helicopter Access to Conduct Forest
Inventory and Analysis (FIA) in
Wilderness, in Tongas and Kedgwick
National Forest, AK. Wait Period
Ends: 12/24/2007. Contact: Ken Post,
907–586–8796. Review to FR Notice
Published 11/09/2007: Extending
Wait Period from 12/10/2007 to 12/
24/2007 and Correction to Title.
Dated: November 19, 2007.
Robert W. Hargrove,
Director, NEPA Compliance Division, Office
of Federal Activities.
[FR Doc. E7–22852 Filed 11–21–07; 8:45 am]
Agency’s draft administrative policies
and procedures for completing the
initial screening and testing under
EPA’s Endocrine Disruptor Screening
Program (EDSP) and the burden and
cost estimates for the related
information collection activities. In two
forthcoming notices in the Federal
Register, EPA will announce the
availability for public review and
comment of: (1) The draft policies and
procedures EPA is considering adopting
for conducting the initial screening and
testing under the EDSP and (2) the draft
Information Collection Request (ICR) for
the initial screening and testing. The
purpose of the public workshop is to
allow the public to ask questions and for
EPA to provide further explanation
about these aspects of the EDSP, which
in turn may facilitate the preparation of
comments.
DATES: The meeting is on Monday,
December 17, 2007, from 9 a.m. to 5
p.m.
Special accommodations: For
information on access or services for
individuals with disabilities, and to
request accommodation of a disability,
please contact the person listed under
FOR FURTHER INFORMATION CONTACT at
least 10 days prior to the meeting to give
EPA as much time as possible to process
your request.
ADDRESSES: The meeting will be held at
the Environmental Protection Agency,
Conference Center—Lobby Level, One
Potomac Yard (South Building), 2777 S.
Crystal Drive, Arlington, VA 22202.
FOR FURTHER INFORMATION CONTACT:
William Wooge, Office of Science
Coordination and Policy (OSCP),
Environmental Protection Agency, 1200
Pennsylvania Ave., NW., Washington,
DC 20460–0001; telephone number:
(202) 546–8476; e-mail address:
wooge.william@epa.gov.
SUPPLEMENTARY INFORMATION:
AGENCY:
I. Who Should Attend?
You may be interested in attending
this workshop if you produce,
manufacture, use, or import pesticide/
agricultural chemicals and other
chemical substances; or if you are or
may otherwise be involved in the testing
of chemical substances for potential
endocrine effects. To determine whether
you or your business may have an
interest in this workshop you should
carefully examine section 408(p) of the
Federal, Food, Drug, and Cosmetic Act
(FFDCA). [21 U.S.C. 346a(p)]
SUMMARY: EPA is convening a 1–day
public workshop to discuss the
II. What is the EDSP?
The EDSP was established in 1998 to
carry out the mandate in section 408(p)
of FFDCA [21 U.S.C. 346a et. seq.],
BILLING CODE 6560–50–P
ENVIRONMENTAL PROTECTION
AGENCY
[EPA–HQ–OPPT–2007–1080; FRL–8341–3]
Endocrine Disruptor Screening
Program; Workshop to Discuss Draft
Policies and Procedures
Environmental Protection
Agency (EPA).
ACTION: Notice.
PO 00000
Frm 00035
Fmt 4703
Sfmt 4703
E:\FR\FM\23NON1.SGM
23NON1
mstockstill on PROD1PC66 with NOTICES
Federal Register / Vol. 72, No. 225 / Friday, November 23, 2007 / Notices
which directed EPA ‘‘to develop a
screening program . . . to determine
whether certain substances may have an
effect in humans that is similar to an
effect produced by a naturally occurring
estrogen, or such other endocrine effect
as the Administrator may designate.’’ If
a substance is found to have an effect,
FFDCA section 408(p)(6) directs the
administrator to take action under
available statutory authority to ensure
protection of public health. That is, the
ultimate purpose of the EDSP is to
provide information to the Agency that
will allow the Agency to evaluate the
risks associated with the use of a
chemical and take appropriate steps to
mitigate any risks. The necessary
information includes identifying any
adverse effects that might result from
the interaction of a substance with the
endocrine system and establishing a
dose-response curve. Section 1457 of
the Safe Drinking Water Act (SDWA)
also authorizes EPA to screen
substances that may be found in sources
of drinking water, and to which a
substantial population may be exposed,
for endocrine disruption potential. [42
U.S.C. 300j–17]
EPA currently is implementing its
EDSP in three major parts that are being
developed in parallel and with
substantial work on each well
underway. This document announces a
public workshop related specifically to
the third component of the EDSP (i.e.,
policies and procedures). The three
parts are briefly summarized as follows:
1. Assay validation. Under FFDCA
section 408(p), EPA is required to use
‘‘appropriate validated test systems and
other scientifically relevant
information’’ to determine whether
substances may have estrogenic effects
in humans. EPA is validating assays that
are candidates for inclusion in the Tier
1 screening battery and Tier 2 tests, and
will select the appropriate screening
assays for the Tier 1 battery based on the
validation data. Validation is defined as
the process by which the reliability and
relevance of test methods are evaluated
for the purpose of supporting a specific
use. The status of each assay can be
viewed on the EDSP website in the
Assay Status table:https://www.epa.gov/
scipoly/oscpendo/pubs/assayvalidation/
status.htm. In addition, on July 13,
2007, EPA published a Federal Register
document that outlined the approach
EPA intends to take for conducting the
peer reviews of the Tier 1 screening
assays and Tier 2 testing assays and
EPA’s approach for conducting the peer
review of the Tier 1 battery (72 FR
38577) (FRL–8138–4). EPA also
announced the availability of a ‘‘list
server’’ (Listserv) that will allow
VerDate Aug<31>2005
16:16 Nov 21, 2007
Jkt 214001
interested parties to sign up to receive
e-mail notifications of EDSP peer review
updates, including information on the
availability of peer review materials to
be posted on the EDSP website.
2. Priority setting. EPA described its
priority setting approach to select
pesticide chemicals for initial screening
on September 27, 2005 (70 FR 567449)
(FRL–7716–9), and announced the draft
list of initial pesticide active ingredients
and pesticide inerts to be considered for
screening under FFDCA on June 18,
2007 (72 FR 33486) (FRL–8129–3). The
Agency expects to finalize this initial
list of chemicals before screening is
initiated in 2008. More information on
EPA’s priority setting approach and the
draft list of chemicals is available at
https://www.epa.gov/scipoly/oscpendo/
prioritysetting. The first 73 pesticide
chemicals to undergo screening is also
referred to as ‘‘initial screening’’ in this
document.
3. Policies and procedures. A
forthcoming Federal Register document
will describe EPA’s draft policies
relating to:
• The procedures that EPA is
considering using to issue orders.
• How joint data development, cost
sharing, data compensation, and data
protection would be addressed.
• Procedures that order recipients
would use to respond to an order.
• Other related procedures and/or
policies.
In addition, EPA has developed an
ICR to obtain the necessary approval
under the Paperwork Reduction Act
(PRA) for the related paperwork
activities. The ICR document, which
describes the information collection
activities and related estimated
paperwork burden and costs, will also
be announced for public review and
comment in a forthcoming Federal
Register document.
III. Why Hold a Workshop?
EPA is holding this workshop to
facilitate the public’s comments on the
draft policies and procedures that EPA
is considering for conducting the initial
screening and testing under the EDSP,
as well as the Agency’s estimated
burden and costs for the related
paperwork activities. The workshop is
an opportunity for the public,
stakeholders and the regulated
community to discuss the draft EDSP
policies and procedures and the draft
ICR documents that are expected to be
released for public comment shortly.
Although the workshop is not intended
to collect oral comments, the Agency
intends to consider the discussion and
will be documenting the discussion for
the public docket.
PO 00000
Frm 00036
Fmt 4703
Sfmt 4703
65733
In addition to attending this
workshop, EPA invites you to provide
comments on the draft policies and
procedures and the draft ICR for initial
EDSP screening and testing. The
Federal Register documents announcing
their availability will include a specific
list of questions on which the Agency is
specifically seeking comment, along
with instructions for how to submit
comments on those documents. This
list, along with an agenda for the
workshop, will be posted on the
Agency’s website and provided at the
workshop. EPA will consider all
comments received and EPA will
announce the availability of the final
versions of the policies and procedures
and the ICR for the initial EDSP
screening and testing in the Federal
Register.
List of Subjects
Environmental protection, Chemicals,
Endocrine disruptors, Pesticides and
pests, Reporting and recordkeeping.
Dated: November 16, 2007.
James Jones,
Acting Assistant Administrator, Office of
Prevention, Pesticides and Toxic Substances.
[FR Doc. E7–22895 Filed 11–21–07; 8:45 am]
BILLING CODE 6560–50–S
ENVIRONMENTAL PROTECTION
AGENCY
[EPA–HQ–OW–2007–1126; FRL–8498–8]
Notice of Availability and Request for
Comment on Draft Plan of Action for
Reducing, Mitigating, and Controlling
Hypoxia in the Northern Gulf of Mexico
and Improving Water Quality in the
Mississippi River Basin
Environmental Protection
Agency (EPA).
ACTION: Notice of Availability and
Request for Public Comment.
AGENCY:
SUMMARY: The Environmental Protection
Agency (EPA), on behalf of the
Mississippi River/Gulf of Mexico
Watershed Nutrient Task Force (Task
Force), invites public comments on the
draft Gulf Hypoxia Action Plan 2008 for
Reducing, Mitigating, and Controlling
Hypoxia in the Northern Gulf of Mexico
and Improving Water Quality in the
Mississippi River Basin (2008 Action
Plan). The Task Force is comprised of
senior policymakers from eight Federal
agencies, nine States, and two Tribal
governments. The Action Plan is the
result of several years of study and
discussion by the members of the Task
Force and many interested officials and
E:\FR\FM\23NON1.SGM
23NON1
Agencies
[Federal Register Volume 72, Number 225 (Friday, November 23, 2007)]
[Notices]
[Pages 65732-65733]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-22895]
-----------------------------------------------------------------------
ENVIRONMENTAL PROTECTION AGENCY
[EPA-HQ-OPPT-2007-1080; FRL-8341-3]
Endocrine Disruptor Screening Program; Workshop to Discuss Draft
Policies and Procedures
AGENCY: Environmental Protection Agency (EPA).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: EPA is convening a 1-day public workshop to discuss the
Agency's draft administrative policies and procedures for completing
the initial screening and testing under EPA's Endocrine Disruptor
Screening Program (EDSP) and the burden and cost estimates for the
related information collection activities. In two forthcoming notices
in the Federal Register, EPA will announce the availability for public
review and comment of: (1) The draft policies and procedures EPA is
considering adopting for conducting the initial screening and testing
under the EDSP and (2) the draft Information Collection Request (ICR)
for the initial screening and testing. The purpose of the public
workshop is to allow the public to ask questions and for EPA to provide
further explanation about these aspects of the EDSP, which in turn may
facilitate the preparation of comments.
DATES: The meeting is on Monday, December 17, 2007, from 9 a.m. to 5
p.m.
Special accommodations: For information on access or services for
individuals with disabilities, and to request accommodation of a
disability, please contact the person listed under FOR FURTHER
INFORMATION CONTACT at least 10 days prior to the meeting to give EPA
as much time as possible to process your request.
ADDRESSES: The meeting will be held at the Environmental Protection
Agency, Conference Center--Lobby Level, One Potomac Yard (South
Building), 2777 S. Crystal Drive, Arlington, VA 22202.
FOR FURTHER INFORMATION CONTACT: William Wooge, Office of Science
Coordination and Policy (OSCP), Environmental Protection Agency, 1200
Pennsylvania Ave., NW., Washington, DC 20460-0001; telephone number:
(202) 546-8476; e-mail address: wooge.william@epa.gov.
SUPPLEMENTARY INFORMATION:
I. Who Should Attend?
You may be interested in attending this workshop if you produce,
manufacture, use, or import pesticide/agricultural chemicals and other
chemical substances; or if you are or may otherwise be involved in the
testing of chemical substances for potential endocrine effects. To
determine whether you or your business may have an interest in this
workshop you should carefully examine section 408(p) of the Federal,
Food, Drug, and Cosmetic Act (FFDCA). [21 U.S.C. 346a(p)]
II. What is the EDSP?
The EDSP was established in 1998 to carry out the mandate in
section 408(p) of FFDCA [21 U.S.C. 346a et. seq.],
[[Page 65733]]
which directed EPA ``to develop a screening program . . . to determine
whether certain substances may have an effect in humans that is similar
to an effect produced by a naturally occurring estrogen, or such other
endocrine effect as the Administrator may designate.'' If a substance
is found to have an effect, FFDCA section 408(p)(6) directs the
administrator to take action under available statutory authority to
ensure protection of public health. That is, the ultimate purpose of
the EDSP is to provide information to the Agency that will allow the
Agency to evaluate the risks associated with the use of a chemical and
take appropriate steps to mitigate any risks. The necessary information
includes identifying any adverse effects that might result from the
interaction of a substance with the endocrine system and establishing a
dose-response curve. Section 1457 of the Safe Drinking Water Act (SDWA)
also authorizes EPA to screen substances that may be found in sources
of drinking water, and to which a substantial population may be
exposed, for endocrine disruption potential. [42 U.S.C. 300j-17]
EPA currently is implementing its EDSP in three major parts that
are being developed in parallel and with substantial work on each well
underway. This document announces a public workshop related
specifically to the third component of the EDSP (i.e., policies and
procedures). The three parts are briefly summarized as follows:
1. Assay validation. Under FFDCA section 408(p), EPA is required to
use ``appropriate validated test systems and other scientifically
relevant information'' to determine whether substances may have
estrogenic effects in humans. EPA is validating assays that are
candidates for inclusion in the Tier 1 screening battery and Tier 2
tests, and will select the appropriate screening assays for the Tier 1
battery based on the validation data. Validation is defined as the
process by which the reliability and relevance of test methods are
evaluated for the purpose of supporting a specific use. The status of
each assay can be viewed on the EDSP website in the Assay Status
table:https://www.epa.gov/scipoly/oscpendo/pubs/assayvalidation/
status.htm. In addition, on July 13, 2007, EPA published a Federal
Register document that outlined the approach EPA intends to take for
conducting the peer reviews of the Tier 1 screening assays and Tier 2
testing assays and EPA's approach for conducting the peer review of the
Tier 1 battery (72 FR 38577) (FRL-8138-4). EPA also announced the
availability of a ``list server'' (Listserv) that will allow interested
parties to sign up to receive e-mail notifications of EDSP peer review
updates, including information on the availability of peer review
materials to be posted on the EDSP website.
2. Priority setting. EPA described its priority setting approach to
select pesticide chemicals for initial screening on September 27, 2005
(70 FR 567449) (FRL-7716-9), and announced the draft list of initial
pesticide active ingredients and pesticide inerts to be considered for
screening under FFDCA on June 18, 2007 (72 FR 33486) (FRL-8129-3). The
Agency expects to finalize this initial list of chemicals before
screening is initiated in 2008. More information on EPA's priority
setting approach and the draft list of chemicals is available at http:/
/www.epa.gov/scipoly/oscpendo/prioritysetting. The first 73 pesticide
chemicals to undergo screening is also referred to as ``initial
screening'' in this document.
3. Policies and procedures. A forthcoming Federal Register document
will describe EPA's draft policies relating to:
The procedures that EPA is considering using to issue
orders.
How joint data development, cost sharing, data
compensation, and data protection would be addressed.
Procedures that order recipients would use to respond to
an order.
Other related procedures and/or policies.
In addition, EPA has developed an ICR to obtain the necessary
approval under the Paperwork Reduction Act (PRA) for the related
paperwork activities. The ICR document, which describes the information
collection activities and related estimated paperwork burden and costs,
will also be announced for public review and comment in a forthcoming
Federal Register document.
III. Why Hold a Workshop?
EPA is holding this workshop to facilitate the public's comments on
the draft policies and procedures that EPA is considering for
conducting the initial screening and testing under the EDSP, as well as
the Agency's estimated burden and costs for the related paperwork
activities. The workshop is an opportunity for the public, stakeholders
and the regulated community to discuss the draft EDSP policies and
procedures and the draft ICR documents that are expected to be released
for public comment shortly. Although the workshop is not intended to
collect oral comments, the Agency intends to consider the discussion
and will be documenting the discussion for the public docket.
In addition to attending this workshop, EPA invites you to provide
comments on the draft policies and procedures and the draft ICR for
initial EDSP screening and testing. The Federal Register documents
announcing their availability will include a specific list of questions
on which the Agency is specifically seeking comment, along with
instructions for how to submit comments on those documents. This list,
along with an agenda for the workshop, will be posted on the Agency's
website and provided at the workshop. EPA will consider all comments
received and EPA will announce the availability of the final versions
of the policies and procedures and the ICR for the initial EDSP
screening and testing in the Federal Register.
List of Subjects
Environmental protection, Chemicals, Endocrine disruptors,
Pesticides and pests, Reporting and recordkeeping.
Dated: November 16, 2007.
James Jones,
Acting Assistant Administrator, Office of Prevention, Pesticides and
Toxic Substances.
[FR Doc. E7-22895 Filed 11-21-07; 8:45 am]
BILLING CODE 6560-50-S